MS patients may receive less frequent rituximab infusions without increasing their chances of relapse or disease progression, ...

Myrobalan's experimental therapy MRO-002 is a GPR17 antagonist that's made to promote myelin repair in people with MS and other conditions.

Quantum BioPharma (NASDAQ: QNTM) a biopharmaceutical company advancing innovative biotech assets, announced a joint clinical study with Massachusett ...

Learn about multiple sclerosis (MS), a condition affecting younger individuals, its symptoms, causes, diagnosis, treatment, ...

The resulting decrease in myelin leads to the symptoms of MS. Read on to learn more about MS and spinal cord lesions, including the link between myelin and lesions, how doctors detect lesions on ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Phase III MUSETTE trial comparing a high dose of OCREVUS® (ocrelizumab) intravenous (IV) infusion to the currently approved OCREVUS IV 600 ...

Multiple sclerosis is a long-term disease that damages the brain and spinal cord. It happens when the immune system attacks ...

New findings reveal Black Americans face higher multiple sclerosis, ms rates and mortality while being systematically ...

Alcohol Detoxification and Anti-Hangover Beverage (Available on amazon.com and unbuzzd.com) to be Distributed by FUSION in ...

In MS, the immune system mistakenly attacks myelin, disrupting these vital signals and leading to debilitating symptoms such as fatigue, mobility issues, and cognitive challenges. Dr Fletcher's ...